Results 201 to 210 of about 14,494 (232)

Evaluation of Metabolic Changes in Patients Initiated on Tenofovir Alafenamide Fumarate Therapy

Ankara Üniversitesi Tıp Fakültesi Mecmuası
Aim: Hepatitis B virus (HBV) infection remains a common global health issue affecting millions and may lead to severe complications. The choice of antiviral drugs for effective HBV treatment plays a critical role in patient outcomes, although the side ...
M. Çelik, Yasemin Çöl, Dilara Turan Gökçe, Derya Arı, A. Atay, Meral Akdoğan Kayhan   +5 more
semanticscholar   +1 more source

Emtricitabine/tenofovir alafenamide/emtricitabine/tenofovir disoproxil fumarate

Reactions Weekly, 2021
openaire   +1 more source

Switching Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide Fumarate (TAF) in Hepatitis B/HIV Co-Infection: A Feasibility Study

Clinical Therapeutics
Tenofovir alafenamide (TAF) delivers the active metabolite more efficiently to target cells compared with tenofovir disoproxil fumarate (TDF). Recent studies suggest that TAF is efficacious in treatment naïve individuals who are co-infected with HBV/HIV and may have superior effects on HBV e antigen (HBeAg) seroconversion in this setting.
James Lok, Maria Fernanda Guerra Veloz, Ruth Byrne, Ivana Carey, Kate Childs, Kosh Agarwal, Mark Nelson   +6 more
openaire   +2 more sources

Effect of P-glycoprotein and Cotreatment with Sofosbuvir on the Intestinal Permeation of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Fumarate

Pharmaceutical Research, 2023
Martin Huličiak, I. Lhotská, Hana Kocova-Vlckova, Veronika Halodova, T. Dušek, F. Čečka, F. Staud, I. Vokřál, L. Červený   +8 more
semanticscholar   +1 more source

[Analysis of efficacy and factors influencing sequential combination therapy with tenofovir alafenamide fumarate after treatment with entecavir in chronic hepatitis B patients with low-level viremia].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023
L. P. Liu, X. P. Wu, T. Cai, L. Wang, J. Sun, J. Liang, S. Ma, X. Gan, N. H. Ruan, S. Ge   +9 more
semanticscholar   +1 more source

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

Lancet, The, 2021
Shahin Lockman, Lynda Stranix-Chibanda, Lee Fairlie   +2 more
exaly  

Tenofovir-alafenamide/tenofovir-disoproxil-fumarate

Reactions Weekly, 2018
openaire   +1 more source

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Lancet, The, 2020
Kenneth Mayer, Peter L Anderson, Robert M Grant   +2 more
exaly  

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

Lancet, The, 2013
Michael Martin, Manoj Leethochawalit, Craig W Hendrix   +2 more
exaly  

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

Lancet, The, 2017
Paul E Sax, Anton L Pozniak, Andrea Antinori   +2 more
exaly